Skip to main content

AGAR Surveillance Outcome Programs 2021 Report

The Australian Group on Antimicrobial Resistance (AGAR) annually publishes data on antimicrobial resistance (AMR) and epidemiologic and genetic patterns in bloodstream infections in Australia, relating to three main organisms: enterococcal species, Staphylococcus aureus and gram-negative bacteria.

Downloads

AGAR Surveillance Outcome Programs 2021 Report

Download PDF (4.08 MB)
Download Word (2.65 MB)

Accessibility - We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

Copyright - Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.

Complete this form to request permission to reproduce material produced by the Commission.

 

Description

The 2021 AGAR Report provides analyses of data on AMR associated with bloodstream infections, reported by 30 laboratories servicing 48 public and private health service organisations across Australia in 2021. The Report also includes considerations and implications for patient safety and delivery of care.

Publication year
2022
Resource type
Publication, report or update
Back to top